Belpointe Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,550	Closed	-$66.1K	–	2428
2023 Q1	$66.1K	Hold	12,550	–	–	﹤0.01%	1552
2022 Q4	$35.3K	Buy	+12,550	New	+$35.3K	﹤0.01%	1822